Header Logo

Connection

Stephen Jensik to Antibodies, Monoclonal, Humanized

Back to Details
This is a "connection" page, showing publications Stephen Jensik has written about Antibodies, Monoclonal, Humanized.
Stephen Jensik
Connection Strength
0.161
Antibodies, Monoclonal, Humanized
  1. Efficacy and safety of bleselumab in kidney transplant recipients: A phase 2, randomized, open-label, noninferiority study. Am J Transplant. 2020 01; 20(1):159-171.
    View in: PubMed
    Score: 0.161
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.